tiprankstipranks
Trending News
More News >
Korro Bio (KRRO)
NASDAQ:KRRO
US Market

Korro Bio (KRRO) Financial Statements

Compare
560 Followers

Korro Bio Financial Overview

Korro Bio's market cap is currently $155.04M. The company's EPS TTM is $-5.33; its P/E ratio is -0.64; Korro Bio is scheduled to report earnings on March 12, 2026, and the estimated EPS forecast is $-1.73. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 6.39M$ 2.27M$ 0.00$ 0.00$ 14.07M
Gross Profit$ 2.11M$ 2.27M$ 0.00$ 0.00$ 10.23M
Operating Income$ -87.34M$ -91.91M$ -84.53M$ -59.00M$ -84.03M
EBITDA$ -83.06M$ -88.34M$ -80.90M$ -56.49M$ -80.07M
Net Income$ -117.26M$ -83.58M$ -81.17M$ -58.03M$ -84.69M
Balance Sheet
Cash & Short-Term Investments$ 75.16M$ 126.09M$ 166.15M$ 55.85M$ 130.71M
Total Assets$ 113.51M$ 226.24M$ 221.66M$ 73.74M$ 185.36M
Total Debt$ 43.49M$ 44.77M$ 33.21M$ 166.99M$ 45.60M
Net Debt$ 21.66M$ -10.88M$ -132.94M$ 130.06M$ -34.04M
Total Liabilities$ 62.07M$ 65.83M$ 51.75M$ 172.77M$ 54.53M
Stockholders' Equity$ 51.44M$ 160.41M$ 169.91M$ -99.03M$ 130.82M
Cash Flow
Free Cash Flow$ -79.08M$ -77.98M$ -75.12M$ -58.86M$ -36.54M
Operating Cash Flow$ -78.56M$ -60.07M$ -67.28M$ -53.65M$ -32.09M
Investing Cash Flow$ 43.99M$ -123.35M$ 11.16M$ 11.06M$ -39.50M
Financing Cash Flow$ 685.00K$ 69.36M$ 187.76M$ 18.00K$ 115.94M
Currency in USD

Korro Bio Earnings and Revenue History

Korro Bio Debt to Assets

Korro Bio Cash Flow

Korro Bio Forecast EPS vs Actual EPS